Charles W. Bishop

2.8k total citations · 1 hit paper
72 papers, 2.2k citations indexed

About

Charles W. Bishop is a scholar working on Pathology and Forensic Medicine, Nephrology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Charles W. Bishop has authored 72 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pathology and Forensic Medicine, 24 papers in Nephrology and 13 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Charles W. Bishop's work include Vitamin D Research Studies (34 papers), Parathyroid Disorders and Treatments (20 papers) and Erythrocyte Function and Pathophysiology (10 papers). Charles W. Bishop is often cited by papers focused on Vitamin D Research Studies (34 papers), Parathyroid Disorders and Treatments (20 papers) and Erythrocyte Function and Pathophysiology (10 papers). Charles W. Bishop collaborates with scholars based in United States, Canada and Switzerland. Charles W. Bishop's co-authors include Douglas M. Surgenor, John H. Talbott, Joyce C. Knutson, Stuart M. Sprague, Richard B. Mazess, Stephen A. Strugnell, Jack W. Coburn, Hector F. DeLuca, Barton S. Levine and Hla M. Maung and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Charles W. Bishop

69 papers receiving 2.0k citations

Hit Papers

The red blood cell 1974 2026 1991 2008 1974 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The red blood cell
    1974 379 citations Douglas M. Surgenor, Charles W. Bishop Academic Press eBooks profile →

Peers

Charles W. Bishop
Anthony G.W. Norden United Kingdom
M. A. Venkatachalam United States
J. Edwin Seegmiller United States
Norman Bank United States
Julia L. Troy United States
N. Gretz Germany
T K Gray United States
Hugo Van Baelen Belgium
R. W. E. Watts United Kingdom
Paul O’Connor United States
Anthony G.W. Norden United Kingdom
Charles W. Bishop
Citations per year, relative to Charles W. Bishop Charles W. Bishop (= 1×) peers Anthony G.W. Norden

Countries citing papers authored by Charles W. Bishop

Since Specialization
Citations

This map shows the geographic impact of Charles W. Bishop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles W. Bishop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles W. Bishop more than expected).

Fields of papers citing papers by Charles W. Bishop

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles W. Bishop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles W. Bishop. The network helps show where Charles W. Bishop may publish in the future.

Co-authorship network of co-authors of Charles W. Bishop

This figure shows the co-authorship network connecting the top 25 collaborators of Charles W. Bishop. A scholar is included among the top collaborators of Charles W. Bishop based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles W. Bishop. Charles W. Bishop is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bishop, Charles W., Akhtar Ashfaq, Stephen A. Strugnell, et al.. (2024). Sustained Reduction of Elevated Intact Parathyroid Hormone Concentrations with Extended-Release Calcifediol Slows Chronic Kidney Disease Progression in Secondary Hyperparathyroidism Patients. American Journal of Nephrology. 1–10. 2 indexed citations
3.
4.
Strugnell, Stephen A., Philipp Csomor, Akhtar Ashfaq, & Charles W. Bishop. (2023). Evaluation of Therapies for Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Chronic Kidney Disease. SHILAP Revista de lepidopterología. 9(3). 206–217. 6 indexed citations
5.
Bishop, Charles W., Stephen A. Strugnell, Philipp Csomor, Edelgard Kaiser, & Akhtar Ashfaq. (2022). Extended-Release Calcifediol Effectively Raises Serum Total 25-Hydroxyvitamin D Even in Overweight Nondialysis Chronic Kidney Disease Patients with Secondary Hyperparathyroidism. American Journal of Nephrology. 53(6). 446–454. 10 indexed citations
6.
Buchanan, Grant, et al.. (2016). Vitamin K2 (menaquinone) Supplementation and its Benefits in Cardiovascular Disease, Osteoporosis, and Cancer. SHILAP Revista de lepidopterología. 2(3). 7 indexed citations
7.
Sprague, Stuart M., Joel Z. Melnick, Stephen A. Strugnell, et al.. (2016). Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease. American Journal of Nephrology. 44(4). 316–325. 70 indexed citations
8.
Petkovich, Martin, Joel Z. Melnick, Jay A. White, et al.. (2014). Modified-release oral calcifediol corrects vitamin D insufficiency with minimal CYP24A1 upregulation. The Journal of Steroid Biochemistry and Molecular Biology. 148. 283–289. 34 indexed citations
9.
Sprague, Stuart M., Samir Tabash, Martin Petkovich, et al.. (2014). Modified-Release Calcifediol Effectively Controls Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Chronic Kidney Disease. American Journal of Nephrology. 40(6). 535–545. 42 indexed citations
10.
Coburn, Jack W., Hla M. Maung, Michael J. Germain, et al.. (2004). Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4. American Journal of Kidney Diseases. 43(5). 877–890. 116 indexed citations
11.
Upton, Robert A., et al.. (2003). Pharmacokinetics of doxercalciferol, a new vitamin D analogue that lowers parathyroid hormone. Nephrology Dialysis Transplantation. 18(4). 750–758. 11 indexed citations
12.
Byford, Valarie, Stephen A. Strugnell, Ruth D. Coldwell, et al.. (2002). Use of vitamin D4 analogs to investigate differences in hepatic and target cell metabolism of vitamins D2 and D3. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1583(2). 151–166. 7 indexed citations
13.
Walczak, J, Hadley Wood, George Wilding, et al.. (2001). Prostate cancer prevention strategies using antiproliferative or differentiating agents. Urology. 57(4). 81–85. 25 indexed citations
14.
15.
16.
Levine, Barton S., Richard B. Mazess, Charles W. Bishop, et al.. (1997). Effective suppression of parathyroid hormone by 1α-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism. Kidney International. 51(1). 317–323. 101 indexed citations
17.
Coburn, J. W., et al.. (1996). 1 -Hydroxy-vitamin D2: a new look at an 'old' compound. Nephrology Dialysis Transplantation. 11(supp3). 153–157. 23 indexed citations
18.
Jones, Glenville, Valarie Byford, H.L.J. Makin, et al.. (1996). Anti-proliferative activity and target cell catabolism of the vitamin D analog 1α,24(S)-(OH)2D2 in normal and immortalized human epidermal cells. Biochemical Pharmacology. 52(1). 133–140. 22 indexed citations
19.
Bishop, Charles W.. (1991). A new format for the medical record.. PubMed. 8(4). 208–15. 2 indexed citations
20.
Surgenor, Douglas M. & Charles W. Bishop. (1974). The red blood cell. Academic Press eBooks. 379 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anthony G.W. Norden Breakdown of academic impact, for papers by M. A. Venkatachalam Breakdown of academic impact, for papers by J. Edwin Seegmiller Breakdown of academic impact, for papers by Norman Bank Breakdown of academic impact, for papers by Julia L. Troy Breakdown of academic impact, for papers by N. Gretz Breakdown of academic impact, for papers by T K Gray Breakdown of academic impact, for papers by Hugo Van Baelen Breakdown of academic impact, for papers by R. W. E. Watts Breakdown of academic impact, for papers by Paul O’Connor
Rankless by CCL
2026